Pharmacology Med List 10.pdf PDF
Document Details
Uploaded by Deleted User
Tags
Summary
This document is a pharmacology medication list, focusing on epinephrine, atenolol, and bethanechol. It includes information on the expected pharmacological action, therapeutic use, complications, administration, nursing interventions, client education, and evaluation of medication effectiveness for each medication.
Full Transcript
epinephrine Medication anaphylaxis treatment ACTIVE LEARNING TEMPLATE: Week 3 STUDENT NAME _...
epinephrine Medication anaphylaxis treatment ACTIVE LEARNING TEMPLATE: Week 3 STUDENT NAME _____________________________________ Epinephrine MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ advenergic agonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use antagonise Alphal beta 2 receptor Sites anaphylaxis treatment · , ↑ Vascular resistance bronchospasms Local vasoconstriction ↓ mucousal edema ↓ mast cell basophil action Complications Medication Administration Tremor , palpations anxiety restlessness, , Tachycardia , dysrhythmia Hin , subcutaneously IV , · · IM Local Insection Contraindications/Precautions ↳ none preexisting Tachy/dusrhythmia Nursing Interventions manage airway Reassessment 02 · BP Interactions Client Education always carry auto-insector now to use auto-insector Evaluation of Medication Effectiveness unpredictability of anaphyl · Improvement of symptoms& lack of localized aXis bleeding use WI H1zH2 blockers (w/ Intradermal Insections ACTIVE LEARNING TEMPLATES atenolol no astuma : atenolol : ACTIVE LEARNING TEMPLATE: Medication blood pressure anti-hypertensive week 3 STUDENT NAME _____________________________________ atenolol Lots of : MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ anti-hypertensive Beta Adrenergic blockers CATEGORY CLASS ______________________________________________________________________ (sympatholytics PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use ↓ HR · HTN lesp Wi aldosterone-mediated fluid. ↓ BP retention ↓ peripheral resistance Long term treatment Angina pector is : prevents reInfarction following M1. Complications Medication Administration HiN (at baseline Orthostatic hypotension 00 : 1/ day Bradycardia IV : Slowly Contraindications/Precautions ↳ Sinus bradycardia it degree block (conduction delays, , cardiac failure shock orthostatic hypotension Nursing Interventions , history · of asthma · Monitor HR before admin. · DM Hold med If HR < 60 BPM and report · Monitor BP before after administration Interactions · Monitor for signs of heart ca channel blockers Verapamil , and , failure diltiazem Intensify effects of beta blockers other antihypertensives Intensity can hypertensive effects Client Education do not discontinue w/f consulting physician Evaluation of Medication Effectiveness avoid sudden changes in absence of chest pain position absence of asyrhythmias do not crush extended-release tabS normotensive BP self monitor BP and HR control heart failure ACTIVE LEARNING TEMPLATES bethanechol : Medication Urinary retention ACTIVE LEARNING TEMPLATE: week 3 STUDENT NAME _____________________________________ bethanechol MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ cholinergic agonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use ↑ acetylcholine In circulation ↑ bladder muscle tone Urinary Retention · stimulates gastric motility Complications Medication Administration wheezing (bronchospasms po nupotension bradycardia peptic nicer dizziness/fainting Contraindications/Precautions ↳ PAD CAD astuma hyperthyroidism , , , , Parkinson's ↳ UTIS Nursing Interventions VS (HRBP) · 1g0s fall risk Implements Interactions acetylcholinesterase inhibitor · beta blockers Client Education Pregnancy category C Evaluation of Medication Effectiveness Report : · difficulty breathing Increased urine output /6 dizziness/fainting Check BPHR · Do not check If allergic ACTIVE LEARNING TEMPLATES oxybutynin : Medication overactive bladder ACTIVE LEARNING TEMPLATE: week 3 (in cont ). STUDENT NAME _____________________________________ oxybutynin MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ anticholinergic CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use blocks muscarinic rec. In detrusor muscle overactive bladder crelaxes causes contraction of Internal sphincter neurogenic bladder of bladder Complications Medication Administration Xerostomia PO (ER tablets) · : constipation Transdermal patch pupils dilation (rotate site drowsiness Contraindications/Precautions BPH , Liver FAMABUGG ↳ UTls hyperthyroidism HiN , , , fever , angle-closure glaucoma Musthenia gravis, Nursing Interventions , active cardiac dysfunction blurry vision Urinary , , retention 61 obstruction on obstruction 130s · , , monitor urinary retention Interactions Grapefruit · · phenytoin Client Education hard candy lare month ↑ fluid fiber Intake · Evaluation of Medication Effectiveness Report : preventIncont. Urinary retention/infection · dizziness/fainting ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ albuterol MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Beta2 agonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use · inducing bronchial smooth first line acute symptoms muscle relaxation & Inhibiting and prevention of ElB - ↳ exercise induced Immediate hypersensitivity mediator release bronchoconstrictor (B2-Lungs) Complications I side effects Medication Administration Side effects palpations headache Insomnia : , , tachycardia , , Inhaled WI SPACER tremors anxiety paradoxical bronchospasm , hyperactivity Conset 3-5 min) children) , , can be administered w/ complications hypokalemia : nebulizer Contraindications/Precautions - previous allergy E Increase BG (DM) , CV disease , Nursing Interventions pulmonary assessment Tachnausoythmias Vital signs reassessment * consider SABAs and LABAs Interactions Y Long ↳ short acting acting beta agonist I beta-adrenergic blockers Monitor with some , conditions p t moves to antidiabetic drugs · LABAs (albuterol Increase can WBG - whole blood glucosel Client Education use as directed need report increased Evaluation of Medication Effectiveness report chest pain use Reassessment keep log of current · symptoms report new associated symptoms · ACTIVE LEARNING TEMPLATES ' ACTIVE LEARNING TEMPLATE: Medication 4 astma STUDENT NAME _____________________________________ Formoterol MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Beta 2 agonist (LABA) CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Long-term use. needs to be Prescribed WI SABA Complications I side effects Medication Administration Enu blackbox warning : headache throatIrritation pain , , , inhaled · * hupertension edema anxiety change In BP Increased risk of usually combined W/ICs , , , , asthma-related angina arrhythmias F , deaths ; paradoxical Inhaled pokalemia huperglycemia bronchospasms a corticosteroids Contraindications/Precautions ↳ ↓ Blackbox warning DM fallergies Nursing Interventions. · CV disease Remember SABA Hypokalemia Pulmonary assessment · needs to be prescribed Seizures WI LABA ! · VS reassessment Interactions Manu Diuretics · think potassium · TCA- antidepressents Client Education use as directed log current use symptoms Evaluation of Medication Effectiveness Report : chest pain Reassessment new symptoms increased need ACTIVE LEARNING TEMPLATES Medication week 4 ACTIVE LEARNING TEMPLATE: STUDENT NAME _____________________________________ cromolyn legyptian minimal bronchodilatory effect MEDICATION __________________________________________________________________________ : REVIEW MODULE CHAPTER ___________ mast cell stabalizers CATEGORY CLASS ______________________________________________________________________ · very safe med PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use asthma-(long term control or EIB) ↳ decreases histamine release by most cells Complications I side effects Medication Administration : transient cough nebulizer pruritus of nose nose burning sensation of Contraindications/Precautions bronchospasms Nursing Interventions list to lungs before after administration Interactions Client Education educate about side effects : transit cough Evaluation of Medication Effectiveness sensation burning Itchy in nose ACTIVE LEARNING TEMPLATES 4 week ACTIVE LEARNING TEMPLATE: Medication Lungs > - STUDENT NAME _____________________________________ mucousal lining Montelukast MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Leukotriene modifier CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use other meds before leukotrienes are inflammatory chem released Adjunct therapy - this one ! inflammation In contact wi allergy comes. & ecrease it by body when the rhinitis muscles and production of excess > allergic preventing the · · tighten airway of or fluid asthma activation mucus ElB leukotrienes Complications I side effects Medication Administration Liver failure po increased risk of suicidal ideation Contraindications/Precautions ↓ - Liver dysfunction exacerbations severe asthma Nursing Interventions acute asthma meds control wh other status LFTs (liver function tests) · First ↳ not responding to albuterol med very Monitor behavior suicide risk , emergent situation · Interactions · phenytoin · phenobarbital Client Education Report : nint of 3 Liver issue and tenderness Evaluation of Medication Effectiveness O NIV : nausea / vomiting intolerance anorexia & behavior changes : agitation Irritability · insomnia anxiety safe med usually well tolerated : ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication 3 arou of chronic part STUDENT NAME _____________________________________ treatment Of - black Fluticasone COPD MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Inhaled corticosteroids (ICS) CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Inhibition of Immunes Inflammatory systems Long term control therapy for COPD. by suppressing sunthesis secretion , actions of astuma , chemical mediators of Inflam response asthma : allergic rhinitis Complications I side effects Medication Administration inrush URL · inhaled · · rhinitis pharyngitis (sore throat - · intranasal ↳ later Contraindications/Precautions ↳ ↳ DM systemic fungal · Infection · HIN Asteroi current thrush Renal dysfunction Nursing Interventions not start on this pt WI thrush do : do can cause drug on med quickly bt wl thrush already : fungal infections to treat reeducate oral care become much we · · Respiratory assessment Interactions ENT assessment · Administeration teaching · Furosemide · Hypoglycemic agents · ↓ effectiveness of DM meds Client Education. Rinse mouth after med Report worse symptoms Evaluation of Medication Effectiveness do not take more than prescribed Reassessment ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ ipratropium MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ anticholinergics CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Inhibits M3 receptors at smooth · CODD muscle- > pronchodilation ~ decreases broncho constriction long care med not for emergent use, , ·. 4 8 weeks fora dose to effectively work Complications I side effects Medication Administration "Can't see bee spit poop" foul taste , , , · Inhaled Xerostomia · ↑ Op (ocular pressure Urinary retention Contraindications/Precautions ↓ 4 Glaucoma previous allergy BPH benign prostatic hapetrophy ? : Nursing Interventions peanut allergy bladder neck obstructions · Monitor urinary patterns schedule eye exams provide hard candy Interactions wh * usually prescribed B2-adrenergic agonists beta agonist a long acting enhances bronchodilation good interaction Client Education · suck on hard candy eye exams Evaluation of Medication Effectiveness Rea. issues Report Urinary ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ dipenhydramine (beers list-65 1) + MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ H1 antagonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Inhibit action of histamine by seasonal binding to Hl-receptor sites on acute mast cells In respiratory tract insomnia Complications Medication Administration effects : anticholinergic side · po can't poop can't pee , I can't see , , · IV and can't spit) Contraindications/Precautions ↳under 2 years ↳ elderly breastfeeding Urinary retention Nursing Interventions · · BPH HTN glaucoma · advise and gen. ↑ fluid Intake · ↑ ambulation 190 Interactions CNS depressants ETOH · opoids · Benzodiazepines · Client Education · Take before bed ↑ fluids/fiber Evaluation of Medication Effectiveness. as needed take lax Report Urinary retention ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ Fluticasone MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Intranasal steroids CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Reduce circulating numbers of · First line I eosinophils Seasonal allergies ↓ seasonally induced increases in most nasal congestion cells and histamine level Complications I side effects Medication Administration Nose bleeds : epastaxis · Intranasal ↑ OP Contraindications/Precautions Nursing Interventions Interactions Client Education Evaluation of Medication Effectiveness ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication decongestants monic otc Cephedrine , ocal > - STUDENT NAME _____________________________________ pseudoephed NIA MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ decongestants CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Complications Medication Administration Oral · Contraindications/Precautions stimulation (caffeine) HIN Nursing Interventions well tolerated Interactions Client Education Evaluation of Medication Effectiveness ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication decongestants Intranasal oxymetazoline - STUDENT NAME _____________________________________ ex Phenylephrine MEDICATION __________________________________________________________________________. REVIEW MODULE CHAPTER ___________ decongestants CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Nasal Quick relief Congestion sinns · (spranessum) Length of use concerns · epistaxis nose bleed : NO Concerns WIHTN Complications Medication Administration · Intranasal 2x13 days Contraindications/Precautions Nursing Interventions Interactions Client Education Evaluation of Medication Effectiveness ACTIVE LEARNING TEMPLATES do not use Medication Wiasthma ACTIVE LEARNING TEMPLATE: STUDENT NAME _____________________________________ codeine MEDICATION __________________________________________________________________________ Dextromethorphan REVIEW MODULE CHAPTER ___________ stop antitussives : coughing CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use "Cough center" Complications I adverses side effects Medication Administration adverse : avoid cocurrent · confusion admin Wor wh. 2 weeks of · excitementIn discontinuing MAG Irritability Inhibitor nervousness DO NOT USE N/ · serotonin astma Contraindications/Precautions Nursing Interventions Interactions Client Education Evaluation of Medication Effectiveness ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ Guaifenesin MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Mucolytics CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use ↑ effective hydration of the R tract used WICOPD pts. reduces the viscosity of respiratory land vaginal) muchs Complications ladverse Medication Administration adverse : · dizziness headache nausea Kidney stone formation (1g #). Contraindications/Precautions ↳ allergic uxn Nursing Interventions Interactions Client Education ↑ fluids Evaluation of Medication Effectiveness & ensure mobilization of secretions ACTIVE LEARNING TEMPLATES dependence I Week S * tell us Medication tolerance expected the drug has been ACTIVE LEARNING TEMPLATE: chronically used STUDENT NAME _____________________________________ Morphine MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ opioid agonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use treat acute or chronic pain stimulation My and Kappa of - post-op cancer LiD AMI , , , , E SBrain eyes G crisis (sickle cell) , , hemolytic Iside effects( analgesic (H) some analgesic Complications I side effects Medication Administration Sedation physical dependence Transdermal po · · · decreased Respiratory drive IM · IV · meds (Hypoxial * think anticholinergic subcutaneously Sh · Hypotension I can't see can't pee , can't , poops can't spit , · constipation ↳Intestinal obstruction Contraindications/Precautions precautions head insury : contraindicated : Nursing Interventions Hypotension Hypoxia , , slow respiratory Check Us (BP RR , 02 , rate 7 dimensions of pain reevaluate Interactions other CNS depressants opoid agonist - · anticholinergic meas antagonist antihypertensive meds ex do not give opiated JdLO ·. benzodiazepine togetherResp. (oplates & antidepressant MAOI : (depression) already ↓BP > ex. diphenhydramine Client Education cambulation constipation & Interventions Evaluation of Medication Effectiveness lowest dose for shortest duration · ! always reassess caution wh other drugs ACTIVE LEARNING TEMPLATES Patient example NIARR but 99 % 02,... , Immediate GCs , responsive to pain ? (dig Medication knuckle into top of sternum no reaction =. rescue wi Naloxone (IV IM Sub-Q : best for absor). ,. , ACTIVE LEARNING TEMPLATE: coses) (Intranasal will need multiple to save life > - STUDENT NAME _____________________________________ Naloxone MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Opioid antagonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Removes Opioids 1911) Reverse Opioid overdose goes circulatory system and rips off into sites. opioids from their receptor Complications I side effects Medication Administration · pain l vomiting Nausea · IM abstinence syndrome ↓ · IV · Withdraw or pain Hypertension subcutaneous Tachycardia - * new : Intranasal * Contraindications/Precautions precautions head trauma : contraindications previous allergic : reaction Nursing Interventions (extremely rare check vs before I during /after HR 02 saturation · RR pain BP · administered every - 112 life concerns 10 minutes A Interactions why ? It works then , pain ! everything begins to - Opioids go back down, again give it - after 2 doses likely will move to In and put some Client Education kind of continuous · consider Naloxone discharge safety Evaluation of Medication Effectiveness home care · How to prevent in future Reassess Reassess and Reassess , discharge prescription ~ (Intranasal. Naloxone correct perscription ? etc Home ? Suicide ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ Butorphanol MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Opioid agonist and antagonist CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Moderate to severe pain * galistones Mu antagonist adjurect therapy or biliary Kappa agonist : pain control Labor pain procedural sedation Complications I side effects Medication Administration Us alterations Orthostatic hypotension IM decreased RR302 abstinence syndrome IV · bradycardia Hypotension Intranasal · · Contraindications/Precautions work of the AMI : Proven to increase the 9 Opioid dependancy Nursing Interventions e can ~ same effects of Naloxone send do not stop abruptly (Withdraw symptoms) * dependence tolerance someone Into withdraws know when to hold Interactions Vital signs Other CNS depressants · ETOH GCS anticholinergics antihypertensives · Opioids additive affect (wl other opioa) Client Education - short term use Evaluation of Medication Effectiveness · do not work or drive while taking * Opioid affect ACTIVE LEARNING TEMPLATES Week 6 : can cause low and always think of potassium high potassium Medication and creatinine together ! ACTIVE LEARNING TEMPLATE: ↑ creatinine = ↑ potassium I means the Kidney STUDENT NAME _____________________________________ is working way too hard ! Furosemide MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Loop diuretics CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use most widely and chirride block reabsorption of sodium * fluid overload used and prevent reabsorption of water Hypertension -> ex Large dose extensive diuresis - · in Urine output 10-15 min Complications I side effects Medication Administration electrolyte disturbances · Hypotension · IV Renal failure * tinnits when pushing too po · ototoxicity dehydration fast or nonreversable A IM painful lemergent · should not push faster than : * Ototoxicity · HYPO- Situations 1 V 4 mg/min through. Kalemia. (LONk+) ↓ Contraindications/Precautions * lifes d >> anuria - hard It : pregnancy * digoxin works old potassium but Nursing Interventions mess CV disease , not as hard wid bradycardia HEPTS VS tachycardia or strength of CO : ↑ In WIkt Digoxin = potassium · : potassium depending on Tenare fluid ne mess I antihypertensive agents overload drop in + can daily weights Monitor 130 heart cause digoxin Night up al 3 falls : nightpeeing timing considerations : Toxicity function monitoring consider ECG Interactions Digoxin antihypertensives other diuretics NSAIDS Client Education · VS daily weights Evaluation of Medication Effectiveness * orthostatic hypotension) slow to stand ( Report chest pain alterations in cpipalpations cramping Y potassium sodium tinnitus ACTIVE LEARNING TEMPLATES Medication First line : ACTIVE LEARNING TEMPLATE: hypertension STUDENT NAME _____________________________________ HCTZ : hydrochlorothiazide MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Thiazide Diuretics CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use convoluted tubule HTN act on distal · water excretion peripheral edema secondary to HTN manage , chloride promote sodium , NOT diuresis Complications I side effects Medication Administration dehydration > - fluid shift po electrolyte disturbances k +? Na ? > - too hard works Kidney decreased Urinary output -> > - Renal failure > - Hyperglycemia Increases electrolyte disturbances Contraindications/Precautions ↓ ↓ · Renal impairment/ / lactating (milk babies pregnancy , It alters Kidneys failure CV disease : DM : ↑ Alc : average glu. Nursing Interventions or tho check BP postural hypotension - 115 minu determine fluid volume status vital sign trends daily weights Interactions Ak += dig electrolytes ~ toxicity · Digoxin : Potassium levels other potassium-wasting drugs -> Renal failure Hyperkalemia Hypokalemia - Client Education ↑ output mild early day dosing > - Month or two Evaluation of Medication Effectiveness fluid Intake to take effect B slow to rise ACTIVE LEARNING TEMPLATES of Medication weakest ACTIVE LEARNING TEMPLATE: diuretics STUDENT NAME _____________________________________ spironolactone MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Potassium-sparing diuretics CATEGORY CLASS ______________________________________________________________________ & holds on to t ↑ BP works to lower + PURPOSE OF MEDICATION , Expected Pharmacological Action · HTN Diuresis - aldosterone inhibitor Hyperaldosteronism ↑ Therapeutic Use · · weakest diuretic Inhibits aldosterone In DCT polycystic ovarian minimize potassium loss syndrome collecting ducts · Acne Hirsutism Complications I side effects Medication Administration · Hyperkalemia · Po ~ labs : creatinine potassium Gynecomastia menstrual irregularities Contraindications/Precautions · Pregnancyllactation a Hyperkalemia Renal failure metabolic acidosis Nursing Interventions It do not High : give Monitor 150s daily weights electrolytes vs (orthostatic check ! ) Interactions Lower BP Ace Inhibitor/ARB 3 blood pressure k increasing med High potassium food avoid Client Education full of k + - avoid salt substitutes (MBP) · BP Evaluation of Medication Effectiveness Report : I hyperkalemia